TOP STORIES

Fighting back against 340B criticisms

Three pharmacy experts explain why they believe the 340B Drug Program is a needed safety net for safety net hospitals. Read it

The new patient-centered pharmacy

ACOs and medical homes have set the pace for an emerging trend toward patient-centered pharmacies—that could connect all the pieces of the healthcare puzzle. Find out more

First generic MS drug could have big impact

FDA's approval of the first generic version of Copaxone for treating patients with relapsing forms of multiple sclerosis has industry insiders contemplating payer coverage strategies. Find out why

MOST POPULAR IN PHARMACY

5 drug categories having the biggest impact on pharma spending

Cystic fibrosis is one drug category that may command the most impact on pharma spending in the near future. Read about others

July 13, 2015

Get the free app!

UBM MEDICA